The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A biomarker-directed, multi-center phase II/III study of ctDNA molecular response adaptive immuno-chemotherapy in patients with non-small cell lung cancer (BR.36).
 
Valsamo Anagnostou
Honoraria - Foundation Medicine; Personal Genome Diagnostics
Consulting or Advisory Role - AstraZeneca; NeoGenomics Laboratories
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Delfi Diagnostics (Inst); Personal Genome Diagnostics (Inst)
 
Sara Moore
Honoraria - AstraZeneca; Bristol-Meyers Squibb; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Pfizer; Roche
Research Funding - AstraZeneca (Inst)
 
Penelope Bradbury
Honoraria - OncologyEducation
Consulting or Advisory Role - RAPT Therapeutics
(OPTIONAL) Uncompensated Relationships - Abbvie; AstraZeneca; Bristol-Myers Squibb; Merck; Mirati Therapeutics
 
Cheryl Ho
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; GlaxoSmithKline Canada; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer; Roche; Sanofi; Sterimax
Research Funding - AstraZeneca (Inst); Roche Canada (Inst)
 
Rosalyn Juergens
Honoraria - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen Oncology; Jazz Pharmaceuticals; Merck Sharp & Dohme; Mirati Therapeutics; Novartis Canada Pharmaceuticals Inc; Pfizer; Roche Canada; Sanofi; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; EMD Serono; Fusion Pharmaceuticals; Janssen Oncology; Jazz Pharmaceuticals; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche Canada; Sanofi/Regeneron; Takeda
Research Funding - Alkermes (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bold Therapeutics (Inst); Bristol-Myers Squibb (Inst); Fusion Pharmaceuticals (Inst); Janssen (Inst); Macrogenics (Inst); Merck Sharp & Dohme (Inst); mirai (Inst); Novartis (Inst); Pfizer (Inst)
 
Adrian Sacher
Research Funding - Amgen (Inst); AstraZeneca (Inst); BMS (Inst); Bridgebio (Inst); CRISPR Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Hotspot Therapeutics (Inst); Iovance Biotherapeutics (Inst); Lilly Loxo (Inst); Merck (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Amgen; Genentech/Roche; Merck
(OPTIONAL) Uncompensated Relationships - Amgen; Genentech/Roche; Merck
 
Sofia Genta
No Relationships to Disclose
 
Lacey Pitre
No Relationships to Disclose
 
Michela Febbraro
Honoraria - AstraZeneca; Bristol-Myers Squibb/Pfizer; Daiichi Sankyo/Lilly; Merck; Roche; Taiho Oncology
Travel, Accommodations, Expenses - Merck
 
Julie Brahmer
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Genmab; GlaxoSmithKline; Janssen Oncology; Mestag Therapeutics; RAPT Therapeutics; Sanofi; Summit Therapeutics
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Other Relationship - Bristol-Myers Squibb; Merck; Regeneron
 
Egor Avrutin
No Relationships to Disclose
 
Pierre-Olivier Gaudreau
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Novartis (Inst); Repare Therapeutics (Inst); Repare Therapeutics (Inst)
 
Mark Sausen
Employment - LabCorp
Stock and Other Ownership Interests - LabCorp
 
Samik Upadhaya
No Relationships to Disclose
 
Alicia Zhou
No Relationships to Disclose
 
Keyue Ding
No Relationships to Disclose
 
Janet Dancey
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Inivata (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)